BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35066743)

  • 1. A novel combined prognostic nutritional index and aspartate aminotransferase-to-platelet ratio index-based score can predict the survival of patients with hepatocellular carcinoma who undergo hepatic resection.
    Yugawa K; Maeda T; Nagata S; Sakai A; Edagawa M; Omine T; Kometani T; Yamaguchi S; Konishi K; Hashimoto K
    Surg Today; 2022 Jul; 52(7):1096-1108. PubMed ID: 35066743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel and accurate predictor of survival for patients with hepatocellular carcinoma after surgical resection: the neutrophil to lymphocyte ratio (NLR) combined with the aspartate aminotransferase/platelet count ratio index (APRI).
    Ji F; Liang Y; Fu SJ; Guo ZY; Shu M; Shen SL; Li SQ; Peng BG; Liang LJ; Hua YP
    BMC Cancer; 2016 Feb; 16():137. PubMed ID: 26907597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection.
    Ji F; Fu S; Guo Z; Pang H; Chen D; Wang X; Ju W; Wang D; He X; Hua Y; Peng B
    Oncotarget; 2016 Nov; 7(44):72276-72289. PubMed ID: 27472390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative albumin-bilirubin grade combined with aspartate aminotransferase-to-platelet count ratio index predict outcomes of patients with hepatocellular carcinoma within Milan criteria after liver resection.
    Luo H; Li C; Chen L
    Biosci Trends; 2019 May; 13(2):176-181. PubMed ID: 31061272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel prognostic score model based on combining systemic and hepatic inflammation markers in the prognosis of HBV-associated hepatocellular carcinoma patients.
    Zhang T; Liu Z; Zhao X; Mao Z; Bai L
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2246-2255. PubMed ID: 31169437
    [No Abstract]   [Full Text] [Related]  

  • 6. [Predictive Value of Platelet to Lymphocyte Ratio and Prognostic Nutritional Index on Prognosis of Hepatocellular Carcinoma after Liver Resection].
    Qin L; Yang XL; Li C; Luo YL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jul; 49(4):645-648. PubMed ID: 30378321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative aspartate aminotransferase-to-platelet ratio index (APRI) is a predictor on postoperative outcomes of hepatocellular carcinoma.
    Cheng J; Zhao P; Liu J; Liu X; Wu X
    Medicine (Baltimore); 2016 Nov; 95(48):e5486. PubMed ID: 27902606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel online calculator based on noninvasive markers (ALBI and APRI) for predicting post-hepatectomy liver failure in patients with hepatocellular carcinoma.
    Shi JY; Sun LY; Quan B; Xing H; Li C; Liang L; Pawlik TM; Zhou YH; Wang H; Gu WM; Chen TH; Lau WY; Shen F; Wang NY; Yang T
    Clin Res Hepatol Gastroenterol; 2021 Jul; 45(4):101534. PubMed ID: 33067168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of aspartate aminotransferase-to-platelet ratio index based score to assess posthepatectomy liver failure in patients with hepatocellular carcninoma.
    Yugawa K; Maeda T; Nagata S; Shiraishi J; Sakai A; Yamaguchi S; Konishi K; Hashimoto K
    World J Surg Oncol; 2022 Aug; 20(1):248. PubMed ID: 35918753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative aspartate aminotransferase to platelet ratio is an independent prognostic factor for hepatitis B-induced hepatocellular carcinoma after hepatic resection.
    Shen SL; Fu SJ; Chen B; Kuang M; Li SQ; Hua YP; Liang LJ; Guo P; Hao Y; Peng BG
    Ann Surg Oncol; 2014 Nov; 21(12):3802-9. PubMed ID: 24849520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Noninvasive Fibrosis Markers and Postoperative Mortality After Hepatectomy for Hepatocellular Carcinoma.
    Maegawa FB; Shehorn L; Aziz H; Kettelle J; Jie T; Riall TS
    JAMA Netw Open; 2019 Jan; 2(1):e187142. PubMed ID: 30657533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The FIB-4 index is a significant prognostic factor in patients with non-B non-C hepatocellular carcinoma after curative surgery.
    Okamura Y; Ashida R; Yamamoto Y; Ito T; Sugiura T; Bekku E; Aramaki T; Uesaka K
    Langenbecks Arch Surg; 2016 Mar; 401(2):195-203. PubMed ID: 26943655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of nomogram models of inflammatory markers based on clinical database to predict prognosis for hepatocellular carcinoma after surgical resection.
    Mao S; Yu X; Sun J; Yang Y; Shan Y; Sun J; Mugaanyi J; Fan R; Wu S; Lu C
    BMC Cancer; 2022 Mar; 22(1):249. PubMed ID: 35255845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspartate aminotransferase-to-platelet ratio index is associated with liver cirrhosis in patients undergoing surgery for hepatocellular carcinoma.
    Ishizuka M; Kubota K; Kita J; Shimoda M; Kato M; Mori S; Iso Y; Yamagishi H; Kojima M
    J Surg Res; 2015 Mar; 194(1):63-8. PubMed ID: 25291961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic nutritional index predicts short-term outcomes after liver resection for hepatocellular carcinoma within the Milan criteria.
    Ke M; Xu T; Li N; Ren Y; Shi A; Lv Y; He H
    Oncotarget; 2016 Dec; 7(49):81611-81620. PubMed ID: 27835570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A simple, noninvasively determined index predicting hepatic failure following liver resection for hepatocellular carcinoma.
    Ichikawa T; Uenishi T; Takemura S; Oba K; Ogawa M; Kodai S; Shinkawa H; Tanaka H; Yamamoto T; Tanaka S; Yamamoto S; Hai S; Shuto T; Hirohashi K; Kubo S
    J Hepatobiliary Pancreat Surg; 2009; 16(1):42-8. PubMed ID: 19082913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and prognostic nutrition index as preoperative predictors of early mortality after liver resection for huge (≥10 cm) hepatocellular carcinoma.
    Goh BK; Kam JH; Lee SY; Chan CY; Allen JC; Jeyaraj P; Cheow PC; Chow PK; Ooi LL; Chung AY
    J Surg Oncol; 2016 May; 113(6):621-7. PubMed ID: 26861568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspartate aminotransferase-to-platelet ratio predicts response to transarterial chemoembolisation and prognosis in hepatocellular carcinoma patients.
    Tang T; Qiu JL; Li GW; Huang MP; Li Y; Li YJ; Gu SZ
    Clin Radiol; 2018 Mar; 73(3):259-265. PubMed ID: 29032942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspartate aminotransferase-to-platelet ratio index for predicting late recurrence of hepatocellular carcinoma after radiofrequency ablation.
    Zhang X; Xin Y; Yang Y; Chen Y; Cao XJ; Wang Y; Fan Q; Zhou X; Li X
    Int J Hyperthermia; 2022; 39(1):437-445. PubMed ID: 35249443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining Aspartate Aminotransferase-to-Platelet Ratio Index with Future Liver Remnant to Assess Preoperative Hepatic Functional Reserve in Patients with Hepatocellular Carcinoma.
    Mai RY; Zeng J; Lu HZ; Liang R; Lin Y; Piao XM; Gao X; Wu GB; Wu FX; Ma L; Xiang BD; Li LQ; Ye JZ
    J Gastrointest Surg; 2021 Mar; 25(3):688-697. PubMed ID: 32274631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.